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Sweet taste receptors are primarily found in the oral cavity of the mammalian species. 
However, recent studies have shown that sweet taste receptors can be found in extraoral tissues 
such as the pancreas, intestines, and adipose tissue. Our lab has previously found that sweet taste 
receptors are down-regulated on the pancreas in the presence of high plasma glucose levels. In 
order to assess the possibility that sweet taste receptors respond to high levels of glucose by 
suppressing its expression, we wanted to see if they reacted similarly on the intestines. We found 
that intestinal sweet taste receptors are down regulated in the presence of a 24 hour high sucrose 
diet (60% sucrose), and a 7 day high sucrose diet in both wild type (WT) mice on the high 
sucrose diet, and T1R2-KO (lacking sweet taste receptors) mice. We also examined their glucose 
excursion levels, and found that these mice are lacking a normal response to dietary glucose via 
an oral glucose tolerance test (OGTT). This led us to conclude that the mice lacking sweet taste 
receptor expression exhibit abnormal glucose absorption, possibly indicating that sweet taste 
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CHAPTER 1: INTRODUCTION 
 
 
Taste Receptors on the Tongue 
 
Humans use their taste buds to help them distinguish between the types of food they are 
consuming, whether it is delicious, toxic, or unpleasant. There are five taste sensations: sour, 
umami (savory), bitter, salty, and sweet compounds, etc) [1, 2] (Figure 1-1). The T1R family is a 
class-C GPCR and it is responsible for sensing both sweet and umami (i.e. savory tastes of amino 
acids). The T1R gene family encodes for T1R1 (or TAS1R1), T1R2 (or TAS1R2) , and T1R3 (or 
TAS1R3), which hetero-dimerize to form specific receptors for sweet (T1R2 + T1R3) or umami 
(T1R1 + T1R3) taste [3]. Sweet taste receptors (STRs), the heterodimer of T1R2 and T1R3, is 
found on the apical surface of the cell, and allows binding of ligands such as sugar, artificial 
sweeteners, a subset of D-amino acids, and sweet tasting proteins [4].   
 




STR Ligand Binding and Signaling 
 
 STRs bind a variety of ligands that vary across mammalian species. For example, in 
rodents, aspartame is not sucrose-like, and they avoid it. Cats don’t express T1R2 because it is 
deemed a pseudo gene, and in humans the sweet inhibitor, lactisole, is ineffective in the rat. 
Therefore, when conducting these studies, sugar preferences were taken into account [4].  
STRs contain four different ligand binding domains on both the T1R2 and T1R3 subunits. 
Three noteworthy domains include the large extracellular venus flytrap domain (VFTD), which 
is linked to the heptahelical transmembrane domain (TMD) via the short cysteine rich domain 
(CRD)[5, 6]. It has been discovered that the CRD contains nine highly conserved cysteines, and 
the VFTM contains a conserved cysteine that is important for signal transduction once a ligand is 
bound [6]. Each domain has been shown to bind to different ligands, such as glucose, fructose, 
sweet proteins such as brazzein, cyclamate, and some artificial sweeteners. Agonists can bind to 
the VFD of hT1R2 (human) and stabilize the closed conformation, or the agonist can bind to 
either the TMD of either T1R2 or T1R3 [5]. Residues located on the CRD of hT1r3 have been 
found to bind to sweet proteins. There are also positive allosteric modulators (PAMs) that are 
tasteless for human STRs, but are able to enhance the activity of an orthosteric agonist [5]. These 
PAMs bind to the TMD of the receptors and can enhance the activity of the receptor binding, 
and/or affinity of the ligand [5]. 
 Signal transduction begins with the ingestion of chemicals/nutrients (tastants), and a 
signal cascade is mediated via taste receptor cells responsible for umami, sweet, and bitter taste 
when bound to its tastant. When taste receptors are stimulated, the cells becomes depolarized 
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which leads to increased calcium levels within the cell, which in turn leads to exocytosis of a 
neurotransmitter and the activation of afferent taste neurons (9). 
Ligand binding to STRs activates phosphatidylinositol-4,5-bisphosphate 
phosphodiesterase beta-2 (PLC2) causing the hydrolysis of phosphatidynlinositol 4,5- 
bisphosphate (PIP2) to inositol triphosphate (IP3 )and diacylglycerol (DAG). IP3 binding to IP3-
receptors (IP3-Rs) on the endoplasmic reticulum (ER) stimulates calcium release. Calcium then 
activates the transient receptor potential cation channel subfamily M member 5 (TRPM5) 
channels on the cell-surface, allowing sodium influx and cell membrane depolarization. The 
resulting voltage-dependent calcium channel (VDCC) activation leads to calcium influx, and 
elevated intracellular calcium concentrations ([Ca
2+
]i) triggers exocytosis of ATP. In taste cells, 
the release of ATP acts as a paracrine signal to gustatory afferent axons (Figure 1-2). Loss-of-
function studies targeting TRPM5 or PLC2 eliminate all sweet and umami taste responses in 






Figure 1 - 2:  An Illustration depicting the signaling cascade of a lingual sweet taste receptor. 
 
STRs on Extra-oral Tissues 
 
STRs have been found in various tissues other than the lingual epithelial cells, such as the 
nasal epithelium, the enteroendocrine cells of the intestine, the pancreas, adipose tissue, and the 
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brain [4, 9]. Unlike their known function in the mouth, the functions of STRs in nongustatory 
tissues are still elusive.  
STRs of  pancreatic beta-cells were found to be activated by fructose and exhibit 
synergistic effects with glucose to amplify insulin secretion in both mice and human islets [10]. 
By using T1R2-KO mice, Kyriazis et al was able to determine that circulating fructose and 
saccharin (an artificial sweetener) potentiate insulin secretion in mice and in vitro mediated by 
STRs on beta-cells. A STR inhibitor, lactisole, was used in isolated human islets, showing 
diminished fructose induced insulin secretion by the human islets [10]. 
STRs on white adipocytes are expressed during adipogenesis of mouse and human 
precursors upon treatment of artificial sweeteners such as saccharin and acesulfame potassium 
(AceK) [11]. 
STRs on the enteroendocrine cells of the intestines have been found to play a role in both 
glucose absorption and the incretin effect. STR signaling promotes insertion of GLUT2 to the 
apical surface of the enterocytes, and up regulation of SGTL-1, which are both glucose 
transporters [7]. They also promote secretion of GLP-1 and GIP, the two incretin hormones. 
STRs has been purposed to play a role as a gut carbohydrate sensor [8]. Studies in mice lacking 
STR signaling show defective GLP-1 secretion in response to luminal glucose, compared to the 
wild type mice [12]. Collectively, these data suggest that STRs function to coordinate adaptive 
responses of the intestine, beta cells and adipocytes to changes in nutrient availability, 




STRs in the Intestine 
 
Intestinal glucose absorption and its regulation 
 
The gastrointestinal (GI) tract detects many nutrients, non-nutrients, mechanical factors, 
microorganisms, drugs, and toxic chemicals when ingested. Detection of such factors allows the 
organ to react appropriately through stimulation of sensory nerves, or hormonal response. These 
responses help to regulate some of the most important pathways in our system, from nutrient 
digestion and storage, to the many important metabolic pathways needed to keep our body in 
homeostasis.  
 
Digestion of Glucose  
 
Glucose is an energy source for all tissues in the body. Therefore, it is important to be 
properly transported where it is needed. Before their absorption carbohydrates must be digested 
by salivary and pancreatic amylases, and by dissacharidases on the brush border of the 
enterocytes of the small intestine. These complex sugars are digested to monosaccharides and 
now in their proper state to be absorbed by mature enterocytes of the small intestine [13]. 
Sucrose is a common dietary source of carbohydrates, and is digested to both glucose and 
fructose by the enzyme sucrase. These monosaccharides are absorbed into the bloodstream via 
specialized receptors on the brush border membrane facing the lumen. Glucose is a polar 
molecule that requires specialized receptors in order to cross the lipid bilayer of the enterocytes. 
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Two receptors that transport glucose across the cell membrane are the sodium-glucose 




SGLT-1 is the primary glucose transporter across the brush border membrane and into 
the enterocytes. However, it has been seen that not all glucose transport into the cytoplasm of the 
cell is halted when SGLT-1 is not present. It has been shown that GLUT2 (a glucose transporter) 
is also present and brought to the apical membrane of the cell when glucose is sensed inside the 
cell [14]. SGLT-1 is a low capacity, high affinity transporter, and the only transporter capable of 
moving glucose against its concentration gradient [15]. SGLT-1 is a symport transporter that is 
mediated by the energy produced from a Na
+
 electrochemical potential gradient across the brush 
border membrane. This sodium gradient is produced by a sodium/potassium ATPase at the 
basolateral membrane of the enterocyte, which is responsible for pumping three sodium ions out 
of the cells as they are being transported into the cell via SGLT-1. As sodium is being pumped 
out, two potassium ions are being pumped in to maintain the appropriate potential within the cell. 
Two sodium ions are attached to SGLT-1 and allow one glucose molecule to adhere to the 
transporter. Sodium binding allows conformational change of the protein and subsequent binding 
of glucose. The molecules are then transported into the cell, and dissociation is promoted by low 
intracellular sodium concentrations and low affinity sodium and glucose binding within the 
cell[16]. To keep iso-osmolarity within the cell, as SGLT-1 is importing sodium and glucose, 
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water is also taken into the cell leading to the conclusion that water absorption is glucose 
dependent within the upper and mid-intestine [16].  
GLUT2 is a facilitative glucose transporter that is mainly found in the intestines, liver, 
kidney, and pancreatic beta cells and helps mediate glucose homeostasis [17]. GLUT2 is a low 
affinity, and high capacity glucose transporter, and is responsible for the transportation of 
glucose between the enterocyte and the plasma. GLUT2 is also apically translocated via glucose-
induced membrane depolarization triggered by SGLT-1 [17].   
 
 




The large absorptive capacity of glucose into the enterocyte suggests the presence of an 
additional transporter, since SGLT-1 has low absorptive rates  [18]. A study was done to confirm 
GLUT2s presence in the apical membrane using phloretin, (GLUT2 inhibitor), and observing a 
40% decrease in glucose absorption in rat jejunal brush border membrane [18]. It was also shown 
that 30% of fructose absorption is also reduced when phloretin was infused in the intestine, 
indicating that GLUT5 was not the only fructose transporter in the lumen [18]. Prior to a meal, 
there is a low glucose concentration in the lumen, and SGLT-1 is the only active transporter 
bringing glucose into the cell. Postprandial glucose absorption varies in the mechanism of which 
GLUT2 exhibits. Due to SGLT-1s low capacity binding, saturation of SGLT-1 can take place 
after a meal. To help transport glucose into the cell, GLUT2 is able to translocate to the apical 
membrane of the enterocyte when activated. GLUT2 is a reversible receptor that is able to 
secrete and absorb glucose in and out of the cell. When there is low intracellular glucose 
concentration, GLUT2 is able to transport glucose back into the enterocyte in the absence of 
glucose in the gut [16].  
GLUT2 is also known to transport galactose and fructose out of the enterocyte and into 
the blood plasma. However, fructose is mainly transported by GLUT5, another GLUT sugar 
transporter. GLUT5 is a uniporter that mediates fructose secretion from the enterocyte. Fructose 
is absorbed passively along the brush border membrane of the intestine. This occurs 





Regulation of intestinal glucose absorption 
 
In the gastrointestinal (GI) tract, there are 14 or more different types of enteroendocrine 
cells [8].  Luminal nutrients such as carbohydrates and bitter tastants are able to stimulate 
GPCRs on enteroendocrine cells of the GI tract. STRs are expressed on the enteroendocrine K-
cells and L-cells [19].  K-cells, located in the upper small intestine, secrete glucose-dependent 
insulinotropic peptide (GIP). L-cells, located in the lower intestine and colon, are 
enteroendocrine cells that secrete the hormones glucagon-like peptide-1 (GLP-1), GLP-2, and 
peptide YY (PYY). These hormones play a role in the gut regulatory system contributing to 




GIP, a 42-amino acid hormone, was formerly known as gastric inhibitory polypeptide due 
to its inhibitory effect on gastric acid secretion [20]. After secretion from the K cells, it enters the 
bloodstream and is rapidly degraded by dipeptidyl peptidase-4 (DPP-4). Upon cleavage by DPP-
4, GIP loses its insulinotropic effect on the pancreas, which affects the incretin response [20]. It 
is secreted when glucose is present, but it is also responsive when protein and fats are ingested. It 





GLP-1, a 31 amino acid hormone, is encoded by the proglucagon gene, and shares 50% 
homology to the glucagon hormone [22]. GLP-1 is released from the L cells of the distal ileum 
and colon, and is stimulated upon nutrient ingestion. Some functions of this hormone include 
stimulation of insulin secretion via the beta cells of the pancreas, deceleration of gastric 
emptying, inhibition of glucagon, stimulation of somatostatin via direct contact with delta cells 
of the pancreas, stimulation of beta cell proliferation, and inhibition of beta cell apoptosis [22, 
23]. GLP-1 stimulates insulin release via the pancreatic beta cells, thus contributing to the 
incretin effect along with GIP. GLP-1 has a biphasic response, one being an early, rapid (10-15 
min) phase which is followed by a longer (15-30 min) phase [22]. The longer phase is believed 
to be attributed to how long it takes for the nutrients to reach the lower intestine, allowing GLP-1 
to be released upon stimulation of its enteroendocrine L cells. Similar to GIP, GLP-1 is also 





Figure 1 - 4: The effects that GLP-1 has on various tissues. 
 
Glucagon-like peptide 2 (GLP-2) is a 33 amino acid peptide, and is derived from the 
proglucagon gene [24]. Both GLP-1 and GLP-2 are co-secreted from L cells, and are both 
degraded by DPP-4 having short circulating half-lives. GLP-2 is released in response to ingestion 
of carbohydrates and fat, but is not stimulated by protein ingestion [24]. It has been seen that 
GLP-2 is responsible for causing the increased expression of SGLT-1 by enterocytes via 
activation of the intestinal sweet taste receptors [25]. The GLP-2 receptors are found on enteric 
neurons, and have not been found on any epithelial cells [25]. GLP-2 has also been shown to 




The Incretin Effect  
 
GLP-1 and GIP are incretin hormones that help increase insulin release from the pancreas 
by acting on the pancreatic islets. Incretin hormones are known to help reduce blood glucose 
levels by augmenting insulin release. The incretin effect is known as the observation that orally 
ingested glucose is more effective in stimulating glucose secretion from the pancreas as opposed 
to intravenously injected glucose [19].  GIP and GLP-1 bind to their receptors found on the 
pancreatic beta cells, GIPR and GLP-1R, respectively [20]. These G-protein coupled receptors 
activate adneylate cyclase and subsequently increasing levels of cyclic adenosine 
monophosphate (cAMP) and stimulating glucose dependent insulin secretion.   
 
 
Regulation of glucose absorption by STRs 
 
STRs expressed on enteroendocrine cells are believed to be the sugar sensors of the 
intestine. Margolskee et al showed that the STRs sense luminal glucose concentrations. This 
causes a signaling cascade involving the STRs, alpha gustducin, and other taste signaling 
elements to be activated in enteroendocrine cells, leading to the secretion of hormones such as 
GLP-1 and GIP. He proposes that these hormones are responsible for the up regulation of SGLT-
1 expression on the enterocytes via a paracrine effect [7]. Mice that were knocked out for either 
gustducin or T1R3 failed to increase SGLT-1 expression when fed a high carbohydrate diet [7, 
27]. It has also been implicated that GLUT 2 trafficking into the apical surface of the enterocyte 
is also regulated by STRs in the intestine [27]. The signaling cascade for enteroendocrine cell 
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hormone release via activation of STRs is thought to be similar to the STRs in the tongue. Sweet 
tastants bind to the STR causing the G protein βγ subunit stimulation of PLCβ2 mediated 
synthesis of IP3 leading to Ca
+ 
release from intracellular stores [28]. Increased intracellular Ca
+
 
concentrations trigger TRPM5 and subsequent hormone secretion from enteroendocrine K or L 
cells. These hormones are hypothesized to act on the enteroendocrine cells and promotes up 
regulation of SGLT-1 expression [29].  
 
Overview of Study 
 
In a previous study focused on human and mouse islet secretion of insulin, our lab found 
that islets from mice with hyperglycemia or islets cultured in elevated fasting glucose conditions 
in vitro exhibit a decrease in STR expression, suggesting a link between alterations in plasma 
glucose and STR function [30]. The regulatory effects of ambient glucose on islet STRs led us to 
consider that short term exposure to dietary sugars (i.e. high sucrose) may also alter intestinal 
STRs expression and function.  
It was seen that a short term high sucrose diet (HSD) down-regulates intestinal STRs and 
sugar transporters (SGLT-1, GLUT2, and GLUT5). mRNA expression data indicated similar 
phenotypes between the wild type mice fed a high sucrose diet and T1R2 knock-out (T1R2-KO) 
mice, which showed reduced expression of intestinal STRs and sugar transporters. Glucose 
absorption was compromised amongst the mice lacking normal STR expression and normal 
glucose transporter expressions. This indicates that STRs regulate intestinal glucose absorption 
in response to an oral glucose load.   
15 
  
CHAPTER 2: RESULTS 
 
 
Intestinal Sweet Taste Receptors Are Down-Regulated in Response to Short Term High 
Sucrose Diet (HSD) 
 
To test whether or not a short term exposure to dietary sugars alters intestinal STR 
expression we subjected mice to a diet high in sucrose (60%) for 24 hours. We observed that 
intestinal STRs (T1R2 + T1R3) are significantly down regulated in mice on a HSD (Figure 2-1). 
This is apparent throughout the entire small intestine (all three sections). There have been studies 
done indicating that SGLT-1 and GLUT2 expression is regulated by STRs [14]. Therefore, we 
checked to see how these receptors are affected by a high sucrose diet as well. SGLT-1 did not 
change in expression (Figure 2-1). On the other hand, GLUT2, a secondary glucose transporter, 
expression was suppressed (Figure 2-1), while GLUT5 expression is up-regulated significantly.  
Our lab has independently shown that WT mice fed a 24 hour HSD had significant 
reductions in glucose excursions following an oral glucose tolerance test (OGTT). Plasma insulin 






















































Figure 2- 1: mRNA expression of 24 hour HSD fed WT mice.  Gene expression of STRs (T1R2 and T1R3),  
glucose transporters (SGLT-1 and GLUT2), and fructose transporter (GLUT5) in isolated duodenum (D), jejunum 
(J), and ileum (I) from WT mice in either control diet (CON; black bars) or high sucrose diet (HSD; gray bars). This 
data was measured using quantitative real-time RT-PCR. Data is expressed as fold change from control diet (set at 






T1R3 Receptor is Down-Regulated in T1R2-KO Mice in Response to Short Term High 
Sucrose Diet (HSD)  
 
 To strengthen the correlation between altered intestinal STR expression and glucose 
absorption, we tested whether mice lacking taste receptor signaling also have altered glucose 
absorption if fed a short term CON or HSD. In order to investigate this we collected intestine 
from mice lacking STRs (T1R2-KO), and assessed their gene expression from genes involved in 
glucose absorption.  We noticed that T1R3 is significantly down-regulated in response to HSD 
(Figure 2-2). This finding supports the STRs heterodimeric structure [6]. There were no 
significant changes in glucose transporter SGLT-1, and only minor down regulation of GLUT2 
expression in the duodenum (Figure 2-2). Similar to WT mice (Figure 2-1), GLUT5 expression 














































Figure 2- 2:  mRNA expression of 24 hour HSD fed T1R2-KO mice.  Gene expression of STRs (T1R3),  glucose 
transporters (SGLT-1 and GLUT2), and fructose transporter (GLUT5) in isolated duodenum (D), jejunum (J), and 
ileum (I) from T1R2-KO mice in either control diet (CON; black bars) or high sucrose diet (HSD; gray bars). This 
data was measured using quantitative real-time RT-PCR. Data are expressed as fold change from control diet (set at 




A Short Term High Sucrose Diet (HSD) in T1R2-KO Mice Does Not Alter Plasma Glucose 
Excursions during an Oral Glucose Tolerance Test (OGTT)  
 
We performed an OGTT to assess plasma glucose excursions by T1R2-KO mice fed 
control diet (CON) or HSD. There are no significant changes in glucose excursions between 
T1R2-CON and T1R2-HSD (Figure 2-3A). This suggests that the effects of HSD in WT mice on 
glucose excursions are likely mediated via mechanisms involving STR signaling. These findings 
are further confirmed using OGTT area under the curve (AUC) calculations comparing WT and 
T1R2-KO mice on CON and HSD. T1R2-KO mice on either diet have similar AUC during the 
first 30 minutes of an OGTT to WT mice on HSD (Figure 2-3B). This suggests a HSD regulates 
STR expression leading to alterations in glucose absorption. Thus, WT mice on HSD mimic the 
T1R2-KO phenotypic response to glucose consumption, strengthening our hypothesis that STRs 






Figure 2- 3: OGTT performed on T1R2-KO mice on CON and 24 hour HSD.  2 -3 A:  Plasma glucose 
excursions during an OGTT (1.0 g/kg) in 5-hour fasted T1R2-KO mice fed control diet (T1R2-KO CON; black 
trace) and high sucrose diet (T1R2-KO HSD; gray trace) (n=8 mice/group).  2 -3 B:  Plasma glucose area under the 








Glucose Transporters are Down-Regulated in T1R2-KO Mice Compared to WT Mice 
 
Because T1R2-KO mice have altered glucose absorption irrespective of the diet, we 
compared basal mRNA expression of relevant genes in WT and T1R2-KO mice fed control diet. 
T1R2-KO mice have significantly lower expression of sugar transporters (i.e. glucose and 
fructose) compared to WT mice (Figure 2-4). This further exemplifies our conclusions that 
STRs alter glucose absorption via glucose transporter regulation.  
 
D J I
0 .0 0 0 0 0
0 .0 0 0 0 5
0 .0 0 0 1 0
0 .0 0 0 1 5
0 .0 0 0 2 0




















0 .0 0 0 0
0 .0 0 0 2
0 .0 0 0 4






















0 .0 0 0 0
0 .0 0 2 5
0 .0 0 5 0
0 .0 0 7 5
0 .0 1 0 0






Figure 2- 4:  Absolute mRNA expression of 24 CON fed WT and T1R2-KO. Gene expression of STRs (T1R3),  
glucose transporters (SGLT-1 and GLUT2), and fructose transporter (GLUT5) in isolated duodenum (D), jejunum 
(J), and ileum (I) from T1R2-KO mice in either control diet (CON; black bars) or high sucrose diet (HSD; gray 
bars). This data was measured using quantitative real-time RT-PCR. Data are expressed as absolute values 








STR Expression is Suppressed in 7 Day HSD-WT and HSD- T1R2 Mice 
 
Next, we examined whether STR changes persist during longer term dietary 
interventions. Similar to the 24 hour HSD mice, intestinal gene expression of STRs in mice on a 
7-day HSD are significantly lower than CON (Figure 2-5). This suggests that the transcriptional 
regulation of STR expression in mice fed a HSD persists. We also checked glucose transporter 
expression to see if long term HSD would affect glucose transporter expression as well. SGLT-1 
expression seems to be reduced during a long term HSD feeding (Figure 2-5). This suggests that 
a long term exposure to glucose is able to down regulate SGLT-1 expression, which was not 
present during short term diet (Figure 2-1 and 2-2). GLUT2 expression was also marginally 
down regulated in the ileum of WT mice on the HSD and the jejunum of T1R2-KO mice on 
HSD (Figure 2-5). Consistent with previous findings (Figure 2-4) T1R2-KO mice express lower 
amounts of each receptor. 
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 Figure 2- 5: mRNA expression of 7 day HSD and CON fed WT and T1R2-KO. Gene expression of STRs and 
glucose transporters in isolated duodenum (D), jejunum (J), and ileum (I) from WT and T1R2-KO mice on either 
control diet (CON; black bars) or high sucrose diet (HSD; gray bars) for 7 days. This data was measured using 
quantitative real-time RT-PCR. Data is expressed as fold change from control diet (set at value 1) normalized to 








Long Term (7-Day) HSD Causes Glucose Intolerance in WT and T1R2-KO Mice 
 
To further investigate the long term effects of a HSD we performed an OGTT on both 
wild type (WT) mice, and mice lacking STRs (T1R2-KO). WT and T1R2-KO mice on HSD 
have increased plasma glucose excursions indicating that a week of HSD is adequate to induce 
glucose intolerance (Figure 2-6A). Plasma glucose area under curve (AUC) calculations 
confirmed these findings (Figure 2-6B). No significant changes in body weight between the WT 
and T1R2-KO mice on the HSD were observed (Figure 2-6C). Consistent with the OGTT data, 
fed plasma glucose was elevated in WT mice on HSD, but these effects were absent in T1R2-KO 




Figure 2- 6:  OGTT of 7 day HSD and CON fed WT and T1R2-KO. Figure 2 - 6 A:  Plasma glucose responses 
during an OGTT (1.0g/kg) in 5-hour fasted WT and T1R2-KO mice fed control diet (WT-CON and T1R2-CON; 
black and gray filled trace, respectively) and HSD (WT-HSD and TIR2-HSD); black and gray discontinuous trace, 
respectively (n=5-6 mice/group). Figure 2 - 6 B: Plasma glucose area under the curve (AUC) calculated for a 
duration of the OGTT (0-120 min) in WT mice compared to T1R2-KO mice fed either CON or HSD. Student’s t-
test, *p<0.05, **p<0.01. Figure 2-6C: Body weight (in grams) comparison between WT and T1R2-KO mice on the 
high sucrose diet (HSD). Figure 2-6D: Fed plasma glucose of WT mice on CON and HSD, and of T1R2-KO mice 
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Glucose Oxidation May Account for the Reduced Glucose Absorption in WT and T1R2-
KO mice on 24 hour HSD  
 
There is a possibility that glucose is being metabolized within the enterocytes at a higher 
rate. This would lead to reduced levels of plasma glucose excursions. An oral gavage was 
performed administering 0.50 g/ kg 
13
C-6-glucose (metabolizable) and 0.50 g/kg 3-O-
methylglucose (nonmetabolizable) glucose analogs. 
13
C-6-glucose in WT mice on HSD exhibit 
lower rates of excursion, as opposed to the T1R2-KO mice which exhibit no changes between 
CON and HSD (Figure 2-7A), consistent with previous data (Figure 2-3). Plasma 3-OMG 
appearance did not change between both genotypes and diets (Figure 2-7B). However, at 0 and 5 
minutes, there are significantly lowered levels of 3-OMG being absorbed into the blood, as 
compared to 
13
C-6-glucose excursions (Figure 2-7A-B).  
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Figure 2- 7: OGTT of 24 hour CON or HSD fed WT and T1R2-KO mice using metabolizable (13C-6 glucose) 
and nonmetabolizable (3-O-methyl-glucose) glucose analogs.  Figure 2 - 7 A:  Plasma 13C-6-glucose  Figure 2 - 
7 B: 3-OMG appearance during an OGTT (0.50 g/kg per analogue) in 5-hour fasted WT and T1R2-KO mice fed 
control (CON-WT; black trace) or high sucrose diet (HST-WT; gray trace) (n=7-8 mice/group). AUC from 0-30 






CHAPTER 3: MATERIALS AND METHODS  
 
 
Animals and Mouse Intestine Isolation  
 
All animal experiments were approved by the Institutional Animal Care and Use 
Committee (IACUC). Mice with a homozygous deletion for the T1R2 gene (kindly provided by 
Dr. Zuker and back-crossed on the C57BI/6J strain for 9 generations) were used for our T1R2-
KO cohort. We used nonlittermate WT mice (C57BI/6J) as controls. Cohorts of 6-12 mice were 
placed on a 24 hour or 7 day high sucrose diet (60% sucrose D 12329, Research diets) or control 
diet (60% Corn starch D12328, Research diets). Male mice (C57BI/6J or T1R2-KO) between 8-
10 weeks of age were acclimatized on the control diet for a week prior to diet switch to HSD or 
continuation of control diet.  
mRNA was extracted from intestinal tissue via TRIzol (Ambion, 15596018) and tested to 
assess the regulation of genes involved in STR signaling and glucose absorption. Intestinal tissue 
was extracted under fed conditions. Mice were euthanized via a CO2 chamber followed by 
cervical dislocation. The transcription of genes involved in sugar absorption (i.e. SGLT-1, 
GLUT2, GLUT5) and STR signaling (T1R2, T1R3) were assessed via quantitative real-time 
PCR.  




 Total RNA from sections of the duodenum, jejunum, and ileum were isolated and was 
reverse transcribed to cDNA (1.0µg) using New England BioLabs M-Mulv Reverse 
Transcriptase Kit (M0253L). Quantitative PCRs were performed on an Eppendorf MasterCycler 
using iQ SYBR Green from BioRad Laboratories using the protocol and primer sequences. 
 
Oral Glucose Tolerance Tests  
 
 Oral glucose tolerance tests (OGTTs) were performed in 5-hour fasted mice to measure 
plasma glucose excursions after the 24 hour or 7 day diet intervention. Administration of glucose 
(1 g of glucose per 1 kg of body weight) was performed through an oral gavage and blood 
glucose levels were taken at time points 0, 5, 15, 30, 60, 90, and 120 minutes. Mice gavaged with 
glucose analogs were administered 1.0 g/kg of 
13
C-6-glucose or, for glucose absorption analysis, 
0.50 g/kg 
13
C-6-glucose and 0.50 g/kg 3-O-methyl-glucose (3-OMG).  
 
Surgical Catheterization of Mice  
 
 The Cardiometabolic Phenotyping core implanted catheters into the left common carotid 
artery. They are inserted under isoflurane anesthesia using sterile surgical techniques. The free 
ends of the catheters were externalized behind the head of the rodent and affixed to a silicone 






 Blood was collected at time points 0, 5, 15, and 30 minutes during the OGTT for tracer 
analysis, and 0 and 5 minutes for insulin analysis. The blood was spun down in a centrifuge at 
1.5 g for 20 minutes at 4°C. Plasma (upper phase) was collected and sent to the Pharmacology 
core for plasma analysis of tracers (
13
C-6-glucose and 3-OMG). Insulin levels were also 
quantified from plasma samples at 0 and 5 minutes by using the Mercodia, Ultra-sensitive mouse 




CHAPTER 4: DISCUSSION 
 
 
Based on our data, this study can help further investigation to elucidate how intestinal 
STRs regulate glucose absorption. Since homeostatic glucose absorption rates are important to 
maintain proper metabolic function, it is important to note how dysregulation can play a role in 
metabolic disease such as type 2 diabetes and obesity. Previous studies have shown that high-
fructose consumption has been linked to obesity and the development of adverse metabolic 
effects [31]. Therefore, as the data presented here has proposed, changes in dietary carbohydrate 
composition or glycaemia, frequently seen in obesity and diabetes, modulate glucose availability 
and homeostasis via intestinal and pancreatic regulation of TRs and their signaling [30]. 
Elucidation of this pathway can help formulate treatments for those with metabolic diseases 
pertaining to homeostatic glucose concentrations in the future. 
In this study we tested the effects of acute (24h) and long-term (7-days) high sucrose diet 
(HSD) on glucose absorption and homeostasis. Our lab has independently demonstrated that WT 
mice on a 24 hour HSD exhibit reduced plasma glucose excursions during an oral glucose 
tolerance test (OGTT). Our mRNA expression data performed on WT mice shows that sweet 
taste receptors (T1R2 and T1R3) are significantly down regulated after being placed on the HSD. 
Based on the mRNA expression data (Figure 2-1), we have hypothesized that sweet taste 
receptors may be linked to reduced glucose absorption responses. HSD in T1R2-KO did not 
change plasma glucose excursions during an OGTT (Figure 2-2A), further supporting the link 
between glucose absorption and STR regulation. A previous study suggested that intestinal T1R2 
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signals proper regulation of glucose absorption via SGLT-1 up regulation [32]. However, our 24 
hour HSD-WT expression data suggests that there is no change in SGLT-1 expression (Figure 2-
1C). We observed that the secondary glucose transporter, GLUT2, was also down-regulated 
(Figure 2-1D). This has led us to believe that there may be a mechanism in which basal SGLT-1 
expression is regulated by another pathway besides intestinal STRs signaling [33].  
Although up regulation of SGLT-1 and GLUT2 has been reported previously with 
intestinal STR signaling [14, 25], we see no significant up regulation of SGLT-1 expression in 
our data. There is significant up regulation of GLUT5 in the WT mice fed HSD and the T1R2-
KO fed HSD (Figure 2-1 and 2-2), which is likely due to increase dietary fructose (sucrose is a 
disaccharide of glucose and fructose monomers).  
T1R2-KO mice express lower levels of the STR subunit T1R3 and sugar transporters 
(SGLT-1, GLUT2 and GLUT5) suggesting that STRs regulate these receptors (Figure 2-4). 
There have been studies done demonstrating STR regulation of glucose transporter SGLT-1, 
concluding that STRs signal an increase in SGLT-1 expression [7, 25]. STRs stimulate 
enteroendocrine hormone secretion of  GLP-1, GLP-2, and GIP, which in turn helps stimulate 
SGLT-1 and GLUT2 expression [18, 25]. In order to mimic these stimulatory effects, we fed 
mice a diet high in carbohydrates to stimulate STRs with luminal sugars. However, we observe 
no significant mRNA changes in SGLT-1 between diets. Nevertheless, T1R2-KO mice suggest 
that STRs may regulate GLUT2 and GLUT5 expression, suggesting its role in glucose 
absorption and homeostasis.  
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After 7 day HSD both genotypes exhibited glucose intolerance (Figure 2-6A). These 
findings are similar to a study done showing that chronic HSD leads to glucose intolerance [34]. 
Unfortunately, glucose intolerance leads to many other pathway alterations, making it difficult to 
study glucose absorption directly.  However, most of the mRNA changes in each receptor persist 
(Figure 2-5). Interestingly, the T1R2-KO mice exhibited a down-regulation in GLUT5 
expression on a CON diet, indicating its basal expression (Figure 2-5). It has been found that 
fructose binds to T1R3, possibly have a similar signaling cascade for GLUT5 [35]. This led us to 
think that fructose transport may also be mediated by STRs in the intestine. T1R2-KO mice, 
under fed conditions, exhibit less glucose as opposed to its WT counterparts (Figure 2-6D). This 
may be due to reduced fructose transport since GLUT5 is down regulated, preventing 
hyperglycemia for mice on a HSD. This led to the hypothesis that STRs may mediate GLUT5, 
protecting the blood from glucose concentration imbalances. This must be investigated further.  
An alternative pathway that may occur in mice lacking STR regulation is higher rates of 
glucose oxidation within the enterocytes, which may account for lower glucose excursions. 
Using an oral mix of equal amounts of the non-metabolizable 3-O-methylglucose and the 
metabolizable 
13
C-6-glucose we measured their rate of appearance in the circulation for direct 
comparisons. This way we can indirectly assess the relative contributions of glucose transport 
and glucose metabolism by the enterocytes. Plasma 
13
C-6-glucose appearance was reduced in 
WT-HSD mice and in T1R2 mice compared to WT-CON, confirming our previous OGTT data. 
However, no diet or genotype differences were observed in 3-OMG excursion into the blood, 
supporting the possibility that enterocytes of mice lacking STR signaling metabolize glucose at 





There are various limitations to this study that could be addressed in the future. (i).We 
did not quantify protein expression from both our WT and T1R2-KO mice on HSD. Although 
mRNA expression is a good indicator of the amount of potential protein that is being made, there 
may be an absence in the correlation between the mRNA expression levels compared to protein 
expression levels. One reason for this is the possibility of varied post-transcriptional mechanisms 
that are involved in turning mRNA into protein, therefore limiting our guarantee in protein 
quantification via mRNA concentrations [36]. (ii) We were unable to look for plasma GLP-1 and 
GLP-2 from collected blood samples during an OGTT and on fed mice, which may or may not 
have strengthened the correlation between STR regulations on glucose absorption via hormone 
stimulatory effects on glucose transporters [25]. (iii) There may also be variability in the diet 
response due to the amount of food intake in CON vs HSD mice. This variation can lead to 
differences in mRNA expression due to glucose load. (iv)  In order to assess this hypothesis in a 
more controlled environment, studies of in vitro glucose absorption would have been ideal. 
Finally, (v) checking to see if the glucose not being absorbed was excreted from the body as 
waste via fecal glucose content analysis.  
Summary 
 
This study examined the effects of STR dysregulation on glucose absorption from the 
enterocytes to the blood. It also examined the response that a diet high in carbohydrates had on 
intestinal STR regulation. From our findings we can conclude that intestinal STRs are down 
regulated in response to a high sucrose diet. Along with diet induced suppression of STRs and 
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genetically ablated STR (T1R2-KO) mice, we noticed that STRs play a role in glucose regulation 
into the blood. Along with data indicating lower glucose excursions, we showed lower mRNA 
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